Twenty years ago, Gpc4, a heparan sulfate proteoglycan, was reported to be increased in the brains of AD patients and was initially found to be responsible for neurogenesis (Gysi et al., 2013; Blanchette et al., 2015; Zhang et al., 2015). Here, CD44 is linked to Alzheimer disease.